Ingram Micro to join S&P SmallCap 600, replacing Pacira BioSciences (INGM:NYSE)
Ingram Micro (INGM) will join the S&P SmallCap 600, replacing Pacira BioSciences (PCRX), effective November 17, 2026, according to S&P Dow Jones Indices. Pacira is being acquired by Viatris.
How this was made
The 30-second read
Why it matters
The addition will likely trigger buying from funds that track the index, creating short‑term upside pressure.
Market read
Index inclusion is a material corporate event that can move the stock and affect small‑cap fund flows.
What to watch
Potential supply‑chain constraints for Ingram Micro could offset the index‑driven buying.
Background
Ingram Micro Holding (INGM) is being added to the S&P SmallCap 600, replacing Pacira BioSciences (PCRX). The change takes effect before the market opens on Nov 17, 2026.
Ticker impact
Ingram Micro added to the S&P SmallCap 600, effective before market open on Nov 17, 2026.
likely upward pressure as index funds add shares
First report of the index change; passive fund rebalancing creates immediate demand.
Market effects
Small‑cap distribution sector may see modest inflows as index funds adjust holdings.
U.S. small‑cap market could see a slight lift from the index rebalance.
Limited to U.S. investors tracking the S&P SmallCap 600.
Counterpoint
If the inclusion is seen as a one‑off boost, the stock could face short‑term profit‑taking.
Key entities
- companyIngram Micro Holding
U.S. listed distributor added to the S&P SmallCap 600.
- companyPacira BioSciences
Company being removed from the index.
